Comment on: A British Ophthalmic Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United Kingdom

Jonathan C P Roos^{1

2

3}, Rachna Murthy^{4

5

6}

Affiliations

¹ Thyroid Eye Disease Service, Department of Ophthalmology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
² Department of Ophthalmology, Ipswich Hospital, Heath Road, Ipswich, UK.
³ Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
⁴ Thyroid Eye Disease Service, Department of Ophthalmology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. rachna.murthy@addenbrookes.nhs.uk.
⁵ Department of Ophthalmology, Ipswich Hospital, Heath Road, Ipswich, UK. rachna.murthy@addenbrookes.nhs.uk.
⁶ Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. rachna.murthy@addenbrookes.nhs.uk.

Comment

Jonathan C P Roos et al. Eye (Lond). 2019 Feb.

. 2019 Feb;33(2):327-342.

doi: 10.1038/s41433-018-0303-0. Epub 2018 Dec 12.

Jonathan C P Roos^{1

2

3}, Rachna Murthy^{4

5

6}

¹ Thyroid Eye Disease Service, Department of Ophthalmology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
² Department of Ophthalmology, Ipswich Hospital, Heath Road, Ipswich, UK.
³ Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
⁴ Thyroid Eye Disease Service, Department of Ophthalmology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. rachna.murthy@addenbrookes.nhs.uk.
⁵ Department of Ophthalmology, Ipswich Hospital, Heath Road, Ipswich, UK. rachna.murthy@addenbrookes.nhs.uk.
⁶ Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. rachna.murthy@addenbrookes.nhs.uk.

No abstract available

Conflict of interest statement

The authors declare that they have no conflict of interest.

A British Ophthalmological Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United Kingdom.
Wong Y, Dickinson J, Perros P, Dayan C, Veeramani P, Morris D, Foot B, Clarke L. Wong Y, et al. Eye (Lond). 2018 Oct;32(10):1555-1562. doi: 10.1038/s41433-018-0144-x. Epub 2018 Jun 18. Eye (Lond). 2018. PMID: 29915191 Free PMC article. Review.

1. Wong Y, Dickinson J, Perros P, Dayan C, Veeramani P, Morris D, et al. A British Ophthalmological Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United Kingdom. Eye. 2018;32:1555–62. doi: 10.1038/s41433-018-0144-x. - DOI - PMC - PubMed
1. Perros P, Hegedius L, Bartalena L, Marocci C, Kahaly GJ, Baldeschi L, et al. Graves’ Orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement. Orphanet J Rare Dis. 2017;12:72. doi: 10.1186/s13023-017-0625-1. - DOI - PMC - PubMed
1. Bartalena L, Baldeschi L, Dickinson A, Eckstein A, Kendall-Taylor P, Marcocci C, et al. European Group on Graves’ Orbitopathy (EUGOGO). Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol. 2008;158:273–85. doi: 10.1530/EJE-07-0666. - DOI - PubMed
1. Roos JCP, Paulpandian V, Murthy R. Serial TSH-receptor antibody levels to guide the management of thyroid eye disease: the impact of smoking, immunosuppression, radio-iodine, and thyroidectomy.Eye (Lond). 2018 Nov 6. doi: 10.1038/s41433-018-0242-9. [Epub ahead of print] - PMC - PubMed